Toggle navigation
Home
Search
Services
Blog
Contact
About
Assessment of Glycine Treatment in Schizophrenia
Javitt, Daniel C.
Nathan Kline Institute for Psychiatric Research, Orangeburg, NY, United States
Search 132 grants from Daniel Javitt
Search grants from Nathan Kline Institute for Psychiatric Research
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Fred Hutchinson Cancer Research Center
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Glucocorticoid receptor translational isoforms in asthma
Tailored Interactive Intervention to Increase CRC Screen
Fluconazole in Non-Acute Histoplasmosis, Blastomycosis and Sporotrichosis
Psychophysical and Ep Assessment of Visual Pathology
A New Generation of Tools for Mechanical Systems Simulation
Recently added grants:
Androgen receptors and sex differences in the biological clock
Thalamic Contributions to the developing EEG
Intranasal LIF to improve neurological recovery from perinatal hypoxia-ischema
Caenorhabditis Genetics Center
Genetics of LAM
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Small Research Grants (R03)
Project #
5R03MH056343-02
Application #
2393004
Study Section
Treatment Assessment Review Committee (TA)
Project Start
1996-04-01
Project End
1999-03-31
Budget Start
1997-04-01
Budget End
1999-03-31
Support Year
2
Fiscal Year
1997
Total Cost
Indirect Cost
Institution
Name
Nathan Kline Institute for Psychiatric Research
Department
Type
DUNS #
167204762
City
Orangeburg
State
NY
Country
United States
Zip Code
10962
Related projects
NIH 1997
R03 MH
Assessment of Glycine Treatment in Schizophrenia
Javitt, Daniel C. / Nathan Kline Institute for Psychiatric Research
NIH 1996
R03 MH
Assessment of Glycine Treatment in Schizophrenia
Javitt, Daniel C. / Nathan Kline Institute for Psychiatric Research
Publications
Heresco-Levy, U; Javitt, D C; Ermilov, M et al.
(1999)
Efficacy of high-dose glycine in the treatment of enduring negative symptoms of schizophrenia.
Arch Gen Psychiatry 56:29-36
Comments
Be the first to comment on Daniel Javitt's grant